Another preclinical trial showed sonic Hh and PI3K pathways were activated in PTEN‐deficient glioblastoma, simultaneously targeting both pathways resulted in markedly growth reduction of PTEN‐deficient glioblastomas.645. Here, PIK3CD is linked to glioblastoma.